The database of the Danish Renal Cancer Group

Figures & data

Table 1 Characteristics of the patient population in DaRenCaData

Characteristics	Year of diagnosis (August 1–July 31)
	2010–2011	2011–2012	2012–2013	2013–2014	2014–2015
New cases	705	724	769	880	899
New cases per 100,000 citizens, n	12.7	13.0	13.7	15.6	15.9
Women, n (%)	230 (32.6)	242 (33.4)	267 (34.7)	305 (34.7)	313 (34.8)
Men, n (%)	475 (67.4)	482 (66.6)	502 (65.3)	575 (65.3)	586 (65.2)
Age at diagnosis (years)
Median	65	64	66	67	67
25th percentile	57	56	58	57	57
75th percentile	72	71	73	73	74
Comorbidity at diagnosisa
Score 0, n (%)	354 (50.2)	394 (54.4)	412 (53.6)	463 (52.6)	487 (54.2)
Score 1–2, n (%)	242 (34.3)	218 (30.1)	242 (31.5)	278 (31.6)	277 (30.8)
Score 3+, n (%)	109 (15.5)	112 (15.5)	115 (15.0)	139 (15.8)	135 (15.0)
	Year of surgery (August 1–July 31)
	2010–2011	2011–2012	2012–2013	2013–2014	2014–2015
Surgical procedures, n	591	644	656	749	807
Median age at surgery	64	64	65	65	66

Notes:

a Given as Charlson comorbidity index score.¹⁴ Data from DaRenCa, a subgroup of Dansk Urologisk Cancer Gruppe.¹¹

Abbreviation: DaRenCaData, database of the Danish Renal Cancer Group.

Table 2 Quality indicators and indicator results in DaRenCaData

Indicator	Standard (%)	Type	Result (%)
			Year of diagnosis (August 1–July 31)
			2010–2011^Citation10	2011–2012^Citation11	2012–2013^Citation11	2013–2014^Citation11	2014–2015^Citation11
1a Proportion of localized disease (T1–2, N0/x, M0/x) at diagnosis	≥65	Process	51.2	50.0	52.5	54.3	54.8
1b Proportion of localized disease (T1a, N0/x, M0/x) at diagnosis	Not yet defined	Process	20.0	21.0	23.7	29.8	27.6
2a Proportion of radical nephrectomies for local disease (T1–2) performed laparoscopically	≥85	Process	65.3	75.9	74.4	76.0	76.4
2b Proportion of radical nephrectomies performed laparoscopically	≥65	Process	60.0	62.2	64.9	68.2	66.4
3 30-day morbidity	≤5	Result	4.3	4.3	3.4	4.2	4.4
4 Recurrencea within 3 years	≤25	Result	28.9	29.2
5 30-day mortality	≤0.5	Result	0.7	1.6	0.5	0.7	0.4
6a 1-year observed survival	≥80	Result	81.3	81.9	83.4	84.1
6b 3-year observed survival	Not yet defined	Result	68.2	69.9
7 Hospital stay ≤3 days after an endoscopic or ablative procedure	≥85	Result	68.1	70.9	75.2	75.3	80.1
8 Proportion of T1a tumor treated by radical nephrectomy	≤10	Result	46.7	35.0	25.1	26.8	17.4

Note:

a Recurrence: locoregional or metastatic recurrent disease. TNM, the TNM system for describing the anatomical extent of disease are based on T (the extent of the primary tumour); N, the absence or presence of regional lymph node metastasis; M, the absence or presence of distant metastasis.

Abbreviation: DaRenCaData, database of the Danish Renal Cancer Group.

CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716

 PubMedGoogle Scholar

Dansk Urologisk Cancer Gruppe [homepage on the Internet]Guidelines and Data on Urological Cancer [Updated February 8, 2016]. Available from: http://ducg.dk/nyrecancer/aarsrapporterAccessed June 19, 2016

 Google Scholar

Mehnert F. Personal communication. March 2, 2016.

 Google Scholar